Exploring innovations in cardiovascular medicine at TCT MedTech Forum

As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers.

Diabetes and weight loss drug advertising tops $1B on strength of GLP-1 brand spending

The new class of GLP-1 drug brands is driving diabetes and weight loss prescription drug advertising spending, pushing the combined category to more than $1

March 22, 2024

Lundbeck to buy neurology-focused Longboard Pharmaceuticals in $2.6 billion deal

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth

October 14, 2024

SN Bioscience’s nano-cancer therapy wins orphan drug designation – Pharmaceutical Technology

The orphan drug designation programme is an FDA initiative to support the development of new treatments for rare diseases. Credit: Kateryna Kon via Shutterstock. The

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.